CURE

Education and Inspiration Across the Cancer Journey

Misconceptions about lung cancer, such as the stigma of smoking, are addressed, highlighting that anyone with lungs can ...

How This Guy Stayed Resilient After a Terrifying Blood Cancer Diagnosis

Troy’s gut instinct told him: don’t give in—get busy. He began working closely on treatment with his oncologist, as well as ...

U.S. FDA Approval of RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) Enables the Simplest, Shortest Administration Time for a First-Line Combination Regimen when ...

Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) approved RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj), the first and only subcutaneously (SC) ...
CURE

Testicular Cancer Survivor Shares Story of Courage in New Book

Sluga, a testicular cancer survivor, has been a contributing blogger for CURE ’s website, curetoday.com, since January 2024, ...

KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) Significantly Improved Event-Free Survival, Overall Survival and Pathologic Complete Response R…

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced positive topline results from the Phase ...